"We Envision Growth Strategies Most Suited
to Your Business"
The global dermal fillers market size is expected to gain momentum by reaching USD 6.28 billion by 2028. Fortune Business Insights in its report titled "Dermal Fillers Market Size, Share & COVID-19 Impact Analysis, By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (methyl methacrylate)), Fat Fillers, and Others), By Product (Biodegradable, and Non-Biodegradable), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/ Fullness, and Others), By End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2021-2028.", mentions that the market stood USD 2.84 billion in 2020 and the market registered an impressive CAGR of 10.8% during the forecast period.
Galderma Secures Approval of its Restylane Filler by FDA to Widen its Business Horizon
Galderma announced that the U.S. Food and Drug Administration (FDA) approved its Restylane Kysse. It is a lip dermal filler that adds volume, smoothens upper lip lines for up to one year, and enhances the lip color of people over the age of 21. In addition, it is the first hyaluronic acid (HA) filler made with XpresHAn Technology, and this technology is referred to as OBT technology (Optimal Balance Technology). Furthermore, this lip injection is known to offer satisfactory and proven clinical safe results. Manufacturers are hopeful that this filler will become a leading lip filler in the dynamic U.S. market.
To get a detailed report summary and research scope of this market, click here:
Growing Inclination of Male Demographic toward their Appearance to Augment Market Growth
The inclination of the male demographic towards their appearance is driving the dermal fillers market growth. For instance, an increasing number of men find that age and gravity can negatively impact the appearance of their facial features. Hence, facial fillers treatments are adopted by males for their effectiveness in the reversal of the early gravitational aging that occurs in the face. Another report by ISAPS Global Survey Results 2019 suggests that the male population accounted for around 12.8% of the total global non-surgical procedures.
Investment in R&D by Key Players to Amplify Their Market Positions
The market is consolidated by major companies striving to leverage the lucrative opportunities to maintain a stronghold. These companies are focusing on investments in R&D activities to develop novel dermal fillers to cater to the growing demand from the healthcare sector. Moreover, other key players are trying to maintain their presence by adopting strategies such as collaboration, facility expansion, and the introduction of new products that will contribute to the growth of the market in the forthcoming years.
List of Key Players Profiled in this Market Report
Further Report Findings
Table of Segmentation
Value (USD Billion)
By End User